When did ESPERION THERAPEUTICS INC (ESPR) report earnings last quarter?
ESPERION THERAPEUTICS INC (ESPR) last reported earnings on 3/10/2026.
ESPERION THERAPEUTICS INC (ESPR) Earnings History & Surprises
NASDAQ:ESPR • US29664W1053
Current stock price
2.63 USD
-0.11 (-4.01%)
At close:
2.64 USD
+0.01 (+0.38%)
After Hours:
ESPR Earnings overview
Past quarterly earnings results for ESPERION THERAPEUTICS INC (ESPR), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.03
- Revenue Estimate
- 97.989M
Last Reported
Most Recent- Release Date
- Mar 10, 2026
- Period
- Q4 / 2025
- EPS Reported
- $0.22
- EPS Surprise
- -10.46%
- Revenue Surprise
- -5.37%
Beat Rate
Last 8 Quarters 63%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.22 | 0.25 | -10.46% | 300.00% | 168.446M | 178.01M | -5.37% | 143.73% |
| Q3 2025 | -0.16 | -0.06 | -183.71% | -6.67% | 87.309M | 79.359M | 10.02% | 69.10% |
| Q2 2025 | -0.02 | -0.15 | 86.52% | 93.94% | 82.385M | 64.31M | 28.11% | 11.58% |
| Q1 2025 | -0.21 | -0.16 | -32.97% | -161.76% | 64.995M | 55.425M | 17.27% | -52.81% |
| Q4 2024 | -0.11 | -0.15 | 27.50% | 78.00% | 69.113M | 62.817M | 10.02% | 114.30% |
| Q3 2024 | -0.15 | -0.18 | 16.24% | 59.46% | 51.632M | 52.348M | -1.37% | 52.00% |
| Q2 2024 | -0.33 | -0.19 | -75.67% | 28.26% | 73.834M | 48.443M | 52.41% | 186.33% |
| Q1 2024 | 0.34 | 0.05 | 613.01% | 143.04% | 137.735M | 85.373M | 61.33% | 466.14% |
| Q4 2023 | -0.50 | -0.49 | -1.60% | 34.21% | 32.25M | 29.271M | 10.18% | 71.54% |
| Q3 2023 | -0.37 | -0.44 | 16.08% | 54.32% | 33.969M | 30.175M | 12.57% | 78.78% |
| Q2 2023 | -0.46 | -0.62 | 26.23% | 56.19% | 25.786M | 25.13M | 2.61% | 37.16% |
| Q1 2023 | -0.79 | -0.67 | -18.72% | 15.05% | 24.329M | 22.452M | 8.36% | 29.41% |
| Q4 2022 | -0.76 | -0.86 | 11.37% | 57.06% | 18.8M | 21.264M | -11.59% | 22.08% |
| Q3 2022 | -0.81 | -0.94 | 14.09% | 69.08% | 19M | 20.313M | -6.46% | 31.94% |
| Q2 2022 | -1.05 | -0.94 | -11.17% | 37.13% | 18.8M | 19.083M | -1.48% | -53.81% |
| Q1 2022 | -0.93 | -1.06 | 12.63% | 73.43% | 18.8M | 15.695M | 19.78% | 135.00% |
| Q4 2021 | -1.77 | -2.32 | 23.55% | 54.50% | 15.4M | 14.771M | 4.26% | 60.42% |
| Q3 2021 | -2.62 | -2.86 | 8.41% | 14.66% | 14.4M | 12.126M | 18.75% | 278.95% |
| Q2 2021 | -1.67 | -1.88 | 11.15% | -138.66% | 40.7M | 43.028M | -5.41% | -80.82% |
| Q1 2021 | -3.50 | -2.57 | -36.35% | -23.24% | 8M | 22.475M | -64.40% | 344.44% |
| Q4 2020 | -3.89 | -3.84 | -1.43% | - | 9.6M | 12.766M | -24.80% | - |
| Q3 2020 | -3.07 | -3.50 | 12.41% | - | 3.8M | 5.273M | -27.93% | - |
| Q2 2020 | 4.32 | 1.74 | 148.23% | - | 212.2M | 150.93M | 40.59% | - |
| Q1 2020 | -2.84 | -3.36 | 15.51% | - | 1.8M | 528.87K | 240.35% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-35.16%
Max EPS beat (4)
86.52%
Min EPS beat (4)
-183.71%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
12.50%
Max Revenue beat (4)
28.11%
Min Revenue beat (4)
-5.37%
Analysis
In the last 4 quarters, ESPR has beaten EPS estimates in 1 out of 4 releases
ESPR has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, ESPR reported -35.2% below the EPS estimates on average.
In the last 4 quarters, ESPR has beaten the revenue estimates by 12.5% on average.
Related analysis
ESPERION THERAPEUTICS INC / ESPR Earnings FAQ
Did ESPR stock beat earnings estimates in the most recent quarter?
ESPERION THERAPEUTICS INC (ESPR) missed EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often ESPERION THERAPEUTICS INC beats earnings estimates?
In the last 4 quarters, ESPERION THERAPEUTICS INC (ESPR) has beaten EPS estimates in 1 out of 4 releases.